µo«H¤H¡G neuron (Shun-Sheng Chen) ¬ÝªO¡Gneurology
¤é´Á¡G Wed Apr 1 17:46:48 1998
¼ÐÃD¡G Åöíw¸£¯g»Pºë¯«¯f¤Î¨äÅ@²z
¥H¤U¤å³¹¬°³Í±ÛÂå°|Å@²z®v¼B¨q¯]¤Î¿c¬ü¬X¦b°ªÂ寫¸g¤º¬ì¯f©Ð¶i×, ©Ò§@ªº
¶i׳ø§i¸g¦o̦P·N¶K¥X°Ñ¦Ò, ª©ÅvÄÝì§@ªÌ¡Cì¤å¤w¸g³¯¶¶³Ó±Ð±Â§@¯«¸g¾Ç¤è
±¤§×¹¢¡C
Åöíw¸£¯g»Pºë¯«¯f
Epileptic Psychosis and Encephalopathy
¤@. «e¨¥:
¯«¸g¯e±w±`¦ñÀH©úÅ㪺ºë¯«¯gª¬¡MÅöíwÓ®×§e²{ºë¯«¯gª¬¤ñ¤@¯ë¨ä¥L¤º¬ì
©Î¯«¸g¬ìӮתº¤ñ²v¨Ó±o°ª(Whiteman, Hermann, & Gordon, 1984)¡M¥B¨äºë¯«¯g
ª¬¤j¦h¬Oµo¥Í¦bÅöíwµo¯f¤§«á¡M¦]¦¹¨ä¯gª¬ªºµo¥ÍÀ³»PÅöíw¯e¯f¬ÛÃö¡Cºë¯«¯g
ª¬¥i¦bÅöíw¯fµ{ªº¦UÓ¶¥¬q¥X²{¡Mµo§@®É(ictal)¤Îµo§@«á(post-ictal)ªººë¯«¯gª¬
¬OÄÝ©óÅöíwÓ®×¥»¨ªº¼xÔ¡M¦Óµo§@¶¡(inter-ictal)ªø´Á¤§ºë¯«¯gª¬¤~¬O¦¹¤å³¹±´
°Q¤§«ÂI¡C
¤G. ©w¸q:
¤j¬ù7%ªºÅöíwӮצñÀHµo§@¶¡¤§ºë¯«¯f(inter-ictal psychosis)¡M½ÆÂø©Ê³¡¤À
Åöíw(complex partial epilepsy)¤§±wªÌ§ó°ª¡M¥i¹F10-30%¡C¨ä¯SÂI¥H¤Ûı¡N¦k·Q
¬°¥Dn¯gª¬¡M¤×¨ä¥H³Q®`¤ÎÃö«Y¦k·Q(delusion of persecution & reference)©~¦h¡M
©Mºë¯«¤Àµõ¯g¤£¦P¤§³B¦bÅöíwºë¯«Ó®×ªº¤H»ÚÃö«Y¸û¨Î¡M¤£¹³ºë¯«¤Àµõ¯gÓ®×
·|°h¤Æ¦¨¤ß´¼¯Ê·lª¬ºA(defect state)¡M§Y¨ät©Ê¯gª¬(negative symptoms)¸û¤Ö¡C³q
±`¦bÅöíwµo¥Í14¦~¥ª¥k¤~¥X²{ºë¯«¯f¡C
±¡·P©Êºë¯«¯e±w(mood disorder)¥ç±`¨£©óÅöíw±wªÌ¡M¤Ö¼Æ¥HļÆ{¯g¬°ªí²{¡M
¤j¦h¼Æ¬°¼~Æ{¯g¡M¦³³ø§i¨ä²±¦æ²v°ª¹F55%¡MYª½±µ¸ß°ÝÅöíwӮסM¬ù¦³80%
Ó®×·|³ø§i¦³¼~Æ{¶É¦V¡M¦Û±þ²v¤]¬°¤@¯ë¤H¤§5¦Ü15¿¡C
¤H®æ§ïÅÜ(personality change)¥ç¬OÅöíwÓ®×±`¨£ªººë¯«¬ì°ÝÃD¡M¨ä¯gª¬¥iÂk
¯Ç¬°¤T¤jÃþ: ²Ä¤@Ãþ¬°¬°¹L«×§t¯A(over inclusiveness)¡MÓ®×·|¦³¨¥»y¨±°j
(circumstantial)¡N¹x©T(stickiness)¡N°õµÛ(viscosity)¡N¹L«×®Ñ¼g(hypergraphia)µ¥²{
¶H¡Q²Ä¤GÃþ¬°©Ê»Ùê¡M¦h¼Æ¬°©Ê¬¡°Ê´î¤Ö(hyposexuality)¡M·¥¤Ö¼Æ¬°©Ê¬¡°Ê¼W¥[
©Î©ÊÅܲ§¡Q²Ä¤TÃþ¬°´¼¯à¤§§ïÅÜ¡MÓ®×±`Åܱo¹L«×õ¾Ç©Î©v±Ð¶É¦V(over
religious & philosophic)¡C
§ðÀ»©Ê¦bÅöíwӮר¤W¸û¤Ö¨£¡M¤j¬ù5400¤H¤¤¤~¦³19¤H·|¦³§ðÀ»¦æ¬°¡C
¤T. ¯f²z¤Î¾É¦]:
¦³Åöíw¯gª¬Ó®×µo¥Íºë¯«¯f²zÅܤƪº¤ñ¨Ò¤ñ¤@¯ë¿©±w¤º¬ì¯e¯f©Î¯«¸g¯e¯f
ªºÓ®×µy·L¼W¥[¡M¨äºë¯«¯e¯f¤j³¡¤À¬Oºë¯«¯f¡N¼~Æ{¯g¡N¥H¤ÎµJ¼{¯g¡C
Åöíw¯f¨_ªº¦ì¸m©Mºë¯«¯gª¬¥ç¦³ÃöÁp¡M½ÆÂø©ÊÅöíwµo§@¤S¥iºÙ¬°ºë¯«¹B°Ê
«¬µo§@(psychomotor seizures)¡M¨ä¯f¨_¦ì©óù®¸¤ÎÃä½t¨t²Î¡C°£½ÆÂø©Ê³¡¤ÀÅöíw
µo¥Íºë¯«¯gª¬ªº¾÷²v¸û°ª¥~¡M¬ã¨sÅã¥Ü¡M¥ª°¼¯f¨_¦ü¥G¸û©ö²£¥ÍÃþºë¯«¤Àµõ
(schizophreniform¯gª¬¡M¥k°¼¯f¨_©ö²£¥Í±¡·P¯gª¬¡M¦ý¦¹»¡¤´¥¼Àò©w½×¡M¥ç¦³³ø
§i¨â°¼¦hµo¤§¯f¨_©Î¥ý«e§Y¦³¸£¯fÅܩΦ³ºë¯«¬ìªvÀø°O¿ýªÌ¡M³£¸û®e©ö²£¥ÍÃþ
ºë¯«¤Àµõ¯gª¬¡Cù®¸¯f¨_¸û©öµo¥Í¤H®æ§ïÅÜ¡M¦ýÄY«¼vÅT¨ì¤H»ÚÃö«YªÌ¨Ã¤£¦h
¨£¡C
ÅöíwӮרäµJ¼{¤Î®`©È©Î®£·Wªº·Pı¥i¯àµo¥Í¦b(1)³æ¯Â©Ê³¡¤ÀÅöíw¡M(2)Ó
®×¹ï§Y±Nµo¥ÍSeizureªº¤ß²z¤ÏÀ³¡M(3)µo§@«áªºª¬ºA¡M(4)¥Ñ©óÅöíwªºµo§@¶¡¦æ¬°
§ïÅÜ¡M©Î(5)»PÅöíw¤£¬ÛÃöªºµJ¼{©Î®£·W¡C³o¨ÇӮתº¯gª¬ªº¾÷Âà¥i¯à²M·¡¡M¤]
¥i¯à¦³«Å|¡C¦Ó¨ä¥L·|³y¦¨µJ¼{ªºì¦]¤]À³¦Ò¼{¡M¥]¬Amitral valve prolapse¡N
hyperthyroidism¡Nhypoglycemia¡Npheochromocytoma¡NCushing syndrome¡N
alcohol©Îsedative drug withdrawal¡N¤Îcentral nervous system stimulants¡C¤j³¡¤À
ªº±¡·P¯gª¬¬O¦Ûµo¥B¥ÑÅöíwªº¹q¶Ç¾É¤Þ°_ªº¡M¹³¦Ûµo©Êªº®`©È¬O¥Ñ¤@ºØ¥O¤H®£Äß
ªº«ä·Q©Î¨ë¿E³y¦¨±¡ºü¬ðµMªºÀ£§í¡M¦Ó¤ÏÀ³©Êªº®`©È¬OÓ®×¹ïµo¥Íseizureªº¨Æ
¹êªº¤@ºØ¤ÏÀ³¡C
¦³¬ã¨sÅã¥Ü¡M¥ª°¼¤j¸£¥b²yªº¯f¨_¤Î©ó¨Å饪°¼ª`®gamobarbital¸û®e©ö²£
¥Í¼~Æ{¡MÅöíwӮרä¨â°¼«eºÝÃB¸ªº¥NÁ§C¤U»P¼~Æ{¤]¦³¬ÛÃö¡C³y¦¨¼~Æ{¤§¤ß
ªÀ·|ªº°ÝÃD¥]¬A(1)¦³µ²ºc¯fÅܩθg±`ªºµo§@¦Ó³y¦¨Ó®×ªº¯«¸g¯Ê·l¡Q(2)ªÀ·|
ªºª[µø¤Î¨èªO¦L¶H¡M³y¦¨´N·~¡N¥Í¬¡¡N¤Î¥æ¤Íªº§xÃø¡Q(3)®a®xÃö«Y¥¢½Õ(¦p: ¨Ì
¿à¡N¹L«×«OÅ@¡N±Ë±ó¡Nt¦Vªº¦Û§Ú¤ß¹³)¡M³y¦¨Ó®×¨É¨ü¥Í¬¡¤Î¦¨ªøªº¯à¤O¤U°¡C
¬ã¨sÅã¥Ü°Êª«´¿¦³ù®¸¯f¨_ªºÅöíw¤ñ¸û®e©ö¦³§ðÀ»©Ê¦æ¬°¡M¦pªGӮצb¤Á
°£temporolimbic³¡¦ì«á·|´î¤Ö§ðÀ»©Ê¦æ¬°¡CÁöµM¦p¦¹¡M¯u¥¿³y¦¨Ó®×¦³§ðÀ»©Ê
¦æ¬°ªº¥Í²z¸Ñåì¦]¤´¤£©ú¡M¦ý¦bӮצ³Ãö«Y³Q®`¦k·Q©Î¨ã«Â¯Ù©Ê¤Ûı®É¡M¤ñ
¸û®e©ö¥X²{§ðÀ»¦æ¬°¡C
¥|. Á{§Éªí¼x:
µo§@®É(ictal)ªººë¯«¯gª¬¬O¤Ö¨£ªº¡M¦ý°Ï¿ë¹ïªvÀø¬O«Ü«nªº¡M¦pÅöíw®Éªº
²V¶Ã¡N¤ÏÀ³¤£¨Î¡NÁy³¡¦Ù¦×²Ó·Lªº°}ùC¡M³£¥i¯à·|»Pºë¯«¯gª¬²V²c¡C²³æ©Ê³¡
¤ÀÅöíw¥i¯à·|©óµo§@®É¦ñÀHµÛ¤£¦Pªººë¯«¯f²z§Î¦¡¡M¥]¬A¤Ûı¡N¤H®æ²§±`¡M©Î
¯Ê¥F²{¹ê·P¡M³o¨ÇӮ׳q±`¹ïµo§@·|¦³³¡¤À¯fÃÑ·P¡C
½ÆÂø©Ê³¡¤ÀÅöíw¡M¥i¯à¬O¦]¦Û°Ê¯g©Îļ°Êªºª¾Ä±ª¬ºA²V²c¡M«Ü¤Ö¨£¨ì¦³µo
§@®Éªººë¯«¯f¡C½ÆÂø©ÊÅöíwµo§@¤§¯S¼x¬O²£¥Í¦Û°Ê¯g¡M§YÓ®×·|¥X²{µL¥Øªº¡N
µL·NÃѤU«½Æ°µ¥X©CÄZ¡N©ç¥´¨Åé¡N§ì¨ÌªA¡M¤Î¤@¨Ç¤£«ê·íªº¦æ¬°µ¥¡C¦b¦Û°Ê
¯gµo§@«e³q±`·|¥X²{¤@¨Ç¥ý¥ü¡M¦p¶å¤Ûı¡Nµø¤Ûı¥H¤Îťı¤è±¤§¤Ûı¡Cµo§@
«ùÄò®É¶¡³q±`¥Ñ30¬í¦Ü¼Æ¤ÀÄÁ¡M³Ìªø¥i¹F15¤ÀÄÁ¡Cµo§@«áӮ׳q±`·|¥X²{²V
¶Ã»P¶ÝºÎµ¥¯gª¬¡M¥B¹ïµo§@±¡§ÎµLªk°O±o¡C
µo§@«áªººë¯«¯f¨ä©óÅöíwӮפ¤ªº²±¦æ²v¬ù¦Ü¤Ö25%¡Mµo¥Í¦bÅöíw«á6-48
¤p®É¡M¦Ó¨ä«ùÄò®É¶¡¤j¬ù¦Û¼Æ¤p®É¨ì¼Æ¤ë¤£µ¥¡MÓ®×±`¦ñ¦³ÅãµÛªº±¡ºüÅܤơM
³q±`Ó®×·|¦Û¦æ«ì´_¡M§_«h¥HÃĪ«ªvÀø1-4¤é§Y¥i«ì´_¡C¨ä¤¦k¯gª¬¤@©w±on
»Pºë¯«¯f°Ï¿ë¡M¤¦k¬O¼È®Éªº¡M¦Ó¥B·|¦³¾ãÅ骺»{ª¾¥\¯à°h¤Æ¡M¥]¬Aª`·N¤O¤£
¨Î¡N©w¦V·P»Ùê¡N¦Û¥D©Ê¬¡°Ê»Ùê¡M¥H¤ÎºÎ¯v¯¿¶Ãªº±¡§Î¡C¦Óºë¯«¯fªºª`·N¤O
¬O¥i¥H¶°¤¤ªº¡M¨ä¤Ûı©Î¦k·Q¬O¸û¨t²Î¤Æ¥B¦³²Õ´ªº¡C
ÅöíwӮ׳̱`¨£¨ìªº¬Oµo§@¶¡(interictal)ºë¯«¯f¡M¯S§O¬O¦³ù®¸¯f¨_ªºÓ
®×¡C¦³Ãþ¦üºë¯«¤Àµõ¯gªºÅöíwӮסM¤´«O¦³·Å·xªº±¡·P¤Î¤H®æ¡M¨äµø¤Ûı¸û±`
¨£¡M¦Ó¤£¹³ºë¯«¤Àµõ¯g¸û±`¨£Å¥¤Ûı¡C©T©w¤Æªº«ä¦Ò»Ùê¡N«ä¦Ò¤£³s³e¡N±¡ºü
°hÁY¡N»øª½¡N¥H¤Ît©Ê¯gª¬¦bÅöíwӮר¤W¸û¤Ö¨£¡M¨ä¡«á¸û¨Î¥B¸û¤£»ÝnÃÄ
ª«¤Îªø´Á¦í°|ªvÀø°£«D¨ä¯gª¬»Pºë¯«¤Àµõ¯g¤j¦h¤@P¡M¦]¬°Ó®×¥i¯à¦P®É¿©±w
Åöíw¤Îºë¯«¤Àµõ¯g¡C¤F¸Ñµo§@¶¡ºë¯«¯fªº¦MÀI¦]¤l¦³§U©ó¹w¨¾ªvÀø:
Possible risk factors for interictal psychosis
Genetic predisposition
Female sex
Epilepsy variables
Onset before 20 years of age
Duration of greater than 10 years
History of complex partial seizures
Left-sided seizure focus
?Temporal>frontal lobe seizure focus
Brain pathology
Glial tumors
Hamatomas
Pharmacologic factors
Polytherapy
High-dose antiepileptic drug therapy
Psychosocial factors
Social deterioration
Life events
Ó®×Y¥X²{¥ô¦ó¤@ºØ¦æ¬°°ÝÃD¡NªÀ¥æ©Î¥\¯à¤Wªº°h¤Æ¡M³£»Ýn¼f·Vµû¦ô¡C
Forced normalization(paradoxical normalization)º¥ý¥ÑLandolt©ó1953¦~´£
¥X¡M¬O«üÅöíwӮצb¸g¥Ñ¨}¦nªºÁ{§ÉªvÀø±±¨î«á©ÎÅöíwµo§@¶¡²£¥Íªº«æ©Êºë¯«¯g
ª¬¡C³oºØ²{¶H³Ì±`µo¥Í¦bªxµo©ÊªºÅöíw¡M»P¨ä¥LÅöíwµo§@¶¡ªººë¯«¯f«¬¦¡¸û¦h¼Ë
¤Æ¡M¤j³¡¤ÀÓ®×¥i¥H§Üºë¯«¯fÃĪ«¦¨¥\¦aªvÀø¡C
¤j¬ù¦³10-15%ªº³æ¯Â©ÊÅöíwÓ®×·|²£¥Íµo§@®ÉªºµJ¼{¤Î®`©È¡M¨ä±j«×¤Î«~
½èªº®t²§¬O«D±`¤jªº¡Mµo§@®Éªº®`©È«ùÄò¤j¬ù30-120¬í§Y®ø¥¢¡MµM¦Ó®£·W¦³¥i
¯à·|«ùÄò5-10¤ÀÄÁ¡Cµo§@®Éªº®`©È¥i¯à·|¦]ºë¯«¯fªº¦¸¼Æ¥]¬A¦íºë¯«¯f°|¡Mµo
§@¶¡ªºµJ¼{¡Nºë¯«¯f¶É¦V¡N³Q®`¦k·Q¡Nºë¯«¤Àµõ¡N¥H¤Îөʤº¦V¦Ó¦³©Ò¼W¥[¡Cµo
§@«áªº®`©È©ÎµJ¼{¥i¯à¹³¼~Æ{¤@¼Ë«ùÄò¼Æ¤p®É¨ì¼Æ¤é¡MÓ®×¥i¯à·|¦³µJ¼{©Î®`©È
ªº¼x¥ü¡Mµo§@«áªºµJ¼{±`µo¥Í¦b½ÆÂø©Ê³¡¤ÀÅöíwªºÓ®×¨¤W¡C¿©±wÃä½t«¬Åöíwªº
Ӯפj¬ù¦³66%·|¦³µo§@¶¡ªºµJ¼{¡M¦Ó«C¤Ö¦~µo¯fªºÅöíw±wªÌ¨äÂ÷µo§@¶¡µJ¼{ªº
¦nµo²v¥i¯à·|¼W¥[¡C
¼~Æ{(Depression)¥i¯àµo¥Í¦bÅöíwªº¥ô¤@®É´Á¡M¥¦¬O¤@ºØ«Ü´¶¹Mªº±¡·P¥¢½Õ¡M
µo¥Í¦bÅöíwµo§@«e¼Æ¤p®É¨ì¼Æ¤é¡M¦Ó±µ¤U¨Ó³Ì¥i¯àµo¥Íªº¬O®`©È¡NµJ¼{¤ÏÀ³¡C¦Ó
¦bÅöíwµo§@«á·|«ùÄò¼Æ¤éªº´d¶Ë·P¡Mªø¤[ªº¼~Æ{¥i¯à¦]¦¹¦Ó²£¥Í¡C
¸ÑÂ÷¯g¬OӮצA°Ï¿ë¡N°O¾Ð¡N©Îª¾Ä±ªº¾ãÅé¥\¯à¤W¦³¬ðµM©Î«Ü©úÅ㪺§ïÅÜ¡C
Ó®×¥i¯à·|¦³¼È®É©Ê©ÎºC©Êªº¦Û§Ú¥\¯à¥¢½Õ¡M¥]¬A°O¾Ð³à¥¢¡Nºë¯«©Ê¥¢¾Ð¯g¡N·P
ı¨ì¦Û¤v¦³²Ä¤GºØ¨¤À¡N¦h«¤H®æ¡N¯Ê¥F¦Û§Ú²{¹ê·P¡N·Pı³Qªþ¨µ¥¡C¨ä°O¾Ð¥¢
½Õ¥i¯à¬O§¹¥þªº©Î³¡¤Àªº¡Mµo§@®Éªº¸ÑÂ÷¯g²{¶H¥]¬A¥hÓ¤H¤Æ(¥¢¥hÓ¤Hªº¯u¹ê
·P)¡N¥¢¯u·P¡N¦Ûı¿ù¶Ã¡N¥B¤Ö³¡¤À¤H¦³¤H®æ§ïÅÜ¡C´¿¦³¬ã¨sÅã¥Ü¦b15%ªº³¡¤À
ÅöíwӮפ¤¦³¥hÓ¤H¤Æ¯gª¬¡M18%¦³¥¢¯u·P¡M6%¦³¦Ûı¿ù¶Ã¡C¦³Åöíw¤S¦³Âù«
¤H®æ©Î¦h«¤H®æªº¤H«Ü¤Ö¡MY¦³¡M¤]¬O¦³ºë¯«¯f²zÅܤơCPoriomania¬O¤@ºØªø´Á
ªº²V¶Ã¡MÓ®×¥i¯à·|·Pı¦b®È¹C¥B¹ï³o¬q®É¶¡µo¥Íªº¨Æ¥ó·|¦³¥¢¾Ðªº²{¶H¡M¨ä¯f
¦]¨Ã¤£²M·¡¡M³o¨Çµ}¤ÖªºÓ®×«Ü¤Ö³Q°O¿ý¤U¨Ó¡M¥i¯à¬O¥Hµo§@«á¤¦k©Îºë¯«¯f§e
²{¡C
¸û®e©ö¥X²{¥\À»¦æ¬°ªº¦MÀI¦]¤l¥]¬A: ¤p«ÄÓ®×¼ÉÅS¦b¼É¤O¤§¤U¡N¤p®ÉÔ
¦³¼É¤O¦æ¬°¡N¨k©Ê¡N¥ªºJ¤l¡N§CªÀ¸g¦a¦ì¡N§½³¡©ÎÄjº©©Êªº¯«¸g¯f¨_¡N»{ª¾¯Ê·l¡N
¤ÎÃĪ«¼vÅT(¦p: barbiturates)¡CÁöµM¯«¸g¥~¬ìªº³ø§iÅã¥Ü¬ù¦³25-36%ªºù®¸Åöíw
Ó®×·|¦³§ðÀ»©Ê¡M¦bù®¸¤Á°£¤â³N«áӮתº§ðÀ»¦æ¬°·|©úÅã´î¤Ö¡C
¥|. ¶EÂ_µû¦ô:
1. ¸£¹qªi(EEG): ¥ÑӮ׸£ªiªºÅܤƤ¤¡M¨ó§UÂå®v¶EÂ_¨Ã§ä¥X¨ä¤ÀÃþ¯f¨_¦ì¸m
¤Î¿ë»{¥XÅöíw¼xÔ¸s¡C
2. ¥HMRI¤ÎCT scan¨Ó°Ï¿ë¾ÉPÅöíwªº¯f¨_¡C
3. ¥ÎSPECT©ÎPET scan©ÎMSI¤@¨ÇÃB¥~ªºÀˬd§ä¥XSeizureªºµJÂI¡C
4. ¯«¸g¤ß²z¾ÇÀˬd¥Hµû¦ô¦æ¬°°ÝÃD¡C
¤. ªvÀø:
®Ú¾Úseizureªº«¬¦¡¿ï¾ÜÃĪ«ªvÀø¡M¤]¥i¥H¥Í²z¦^õX¤è¦¡ªvÀø¡C
¦ñÀHºë¯«¯gª¬ªºÅöíw¯g¥»¨§ÜÅöíwÃĪ«¥Hcarbamazepine(Tegretal)¬°²Ä¤@¿ï
¾Ü¡M¥BÀ³¾¨¶q¥H³æ¤@ÃĪ«ªvÀø¡C
§Üºë¯«¯fÃĪ«¥Hthioridazine¡Nfluphenazine¡Nmolindone¬°³Ì¨Î¡M¨ä¥L°ª±j
«×(high potency)ÃĪ«¡M¦phaloperidol¡NpiperazineÃþ¦¸¤§¡Mchlorpromazine°§C
ÅöíwìHȤO¶q·¥±j¡M©yÁ×§K¨Ï¥Î¡C
µo§@®É©Îµo§@«áªºµJ¼{¬Ò¥i¥HantiepilepticÃĪ«ªvÀø¡CY¬Oªxµo©ÊªºµJ¼{©Î
®£·W«h¦Ò¼{¥H¦æ¬°©ÎÃĪ«ªvÀø¡C
§ÜÆ{¾¯¥HMAOI¡Ndoxepine¡Nfluoxetine¸û¨Î¡Mmaprotiline¡Namitriptyline¡N
imipramine¸û©ö°§CÅöíwìHÈ¡C¾YÆQ(lithium)¹ïÅöíwìHȤ§¼vÅTÄݤ¤µ¥¡M©|¯à¨Ï
¥Î¡M¦ýÅöíw±wªÌ¦ñÀHļÆ{¯gª¬¤§²Ä¤@¿ï¾Ü±¡ºüéw¾¯(mood stabilizer)¤´¬°
carbamazepine¡C¼~Æ{ªºµo²{¤ÎªvÀø¹ï¯«¸g¬ìªvÀø¬O»ÝÀu¥ý³B²zªº¡M¦Ó§ÜÆ{¾¯»P
ªvÀøÅöíwªºÃĪ«¨Ã«Dµ´¹ï¤¬¬Û©èIJ¡MÁöµM§ÜÆ{¾¯·|°§CÅöíwªºìHÈ¡M¤j³¡¤Àªº
Ó®×¥i¥H©Ó¨üªvÀø¦Ó¨S¦³¼W¥[seizureµo¥Íªº¦¸¼Æ¡C
BenzodiazepinesÃþÃĪ«¬Ò¦³§ÜÅöíw§@¥Î¡M¬GµL¸T§Ò¡C
¥~¬ìªvÀø: ¤Á°£¤Î©h®§Àøªk¡M¦p: temporal lobectomy¡Nextratemporal
resection¡Ncorpus callosotomy¡Nhemispherectomy¡C
¤ß²zªvÀø¡C
¥tÅöíwӮצ]¨ä¯fµ{¤§ºC©Ê¤Æ¤Î¯S®íÁ{§Éªí²{¡M°£ÃĪ«ªvÀø¥~¡M¤ß²zªÀ·|
¤è±¤§À°¦£(psycho-social approach)¥ç¬Û·í«n
¤». ¨Öµo¯g:
1. Åöíw«ùÄòª¬ºA¡C
2. ¦]¶^˦Өü¶Ë¡C
¤C. Å@²zµû¦ô:
1. ¦¬¶°Ó®×¯f¥v¡M¥]¬A«eÁͯgª¬¤Î¼xÔ¡Nseizure¦æ¬°¡Nµo§@«áªºª¬ºA¡N
Åöíw«ùÄòª¬ºA¡C
2. °O¿ýseizure¬¡°Ê:
a. µo§@«eªº±¡¹Ò¡M¦p: µø¡NÅ¥¡N¶å¡N©ÎIJ¨ë¿E¡Q±¡ºü©Î¤ß²z¤£¥¿Å¡Q
ºÎı¡Q¹L«×´«®ð¡C
b. °Ê§@ªº´yz¡M¥]¬A¨Åé°Ê§@ªº³¡¦ì©Î»øµwªº¶}©l³B¡N°Ê§@ªº«¬¦¡¤Î
²o³sªº³¡¦ì¡Q°Ê§@ªº¶i®i¡Q¬O§_µo§@¶}©l®É¦³¤H¬Ý¨ì¡C
c. ²´»PÀY³¡ªº«º¶Õ¡QÀû¤Õ¤j¤p¡C
d. ¬O§_¦³¦Û°Ê¯g¡M¦p: ®B³¡©çÀ»©Î«ÂЧ]Ã`¡C
e. §¿¥¢¸T©Î¤j«K¥¢¸T¡C
f. ¨C¦¸µo§@ªº«ùÄò®É¶¡¡C
g. ¬O§_¥X²{¥¢¥h·NÃÑ¡M¥H¤Î¨ä«ùÄò®É¶¡¡C
h. µo§@«áªº¦æ¬°¡M¥]¬AµLªk»¡¸Ü¡M¦³µê®z©Î°¾Åõ¡MºÎ¯vª¬ªp¡C
3. Seizure¹ï¤ßªÀ·|ªº¼vÅT¡C
4. ÃĪ«©Î°sºëÀݥΥv¡C
5. ÂåÀø¿í±q©Ê¤ÎÃĪ«ªºªA¥Î¤èªk¡C
6. µû¦ôÓ®×¥±`ªºªÀ¥æª¬ºA¡C
l Å@²zª`·N¨Æ¶µ: ÃĪ«ªA¥Îªº¤£¿í±q¥i¯à·|³y¦¨§ÜÅöíwÃĪ«ªº¤¤¬r¦Ó¼W¥[
seizureªºÀW²v¡C¦b½Õ¾ãÃĪ«¾¯¶q®É¡M»Ý¥ýºÊ´úÃĪ«¦å¤¤¿@«×
¤K. Å@²z¶EÂ_:
A. °ª¦MÀI©Ê¶Ë®`/»P©âÝzµo§@¬ÛÃö
B. °ª¦MÀI©ÊªÀ¥æ¹jÂ÷/»P®`¤H¦b¤½¦@³õ©Òµo¥Í©âÝz¦Ó¨üµ~¬ÛÃö
C. Ó¤H½Õ¾A¯à¤O¥¢½Õ/»PÅöíw³y¦¨ªºªÀ·|¤ß²z¤Î¸gÀÙª¬ªp¬Û¦üÃ
¤E. Å@²z±¹¬I:
1. Á×§K·l¶Ë:
a. ºû«ùÀô¹Ò¦w¥þ¡M¦p: ¨Ï¥Î§ÉÄæ¤Î²¾°£»Ùꪫ¡C
b. ¿ï¾Ü¸û¸Gªº§É¡C
c. ¦bÅöíwµo§@®É¤Å¬ù§ôӮסC
d. ¦bÅöíwµo§@®É¤Å©óӮפf¤º©ñ¸m¥ô¦óª««~¡C
e. Åöíw®ÉÅýÓ®×°¼½ö¥H§K§l¤J²§ª«¡C
f. Åöíw®É¡M«OÅ@Ó®×ÀY³¡¡C
g. Åöíw®É¤£½×Ӯ׬O·NÃѲV¶Ã©Î¤´¥i¬¡°Ê¦Û¦p¡M¬Ò»Ý³¦ñӮסC
h. ´£¨Ñ¦w¥þ´U¥H¨¾¶^¶Ë¡C
i. Ӯצb«ùÄòÅöíwª¬ºA®É¡Mµ¹¤©¾A·í³B¸m¡C
2. ¼W¶i¦]À³¯à¤O:
a. ¦VªÀªA¤Hû¿Ô¸ßªÀ°Ï¸ê·½¦³Ãö¾¯à´_°·¡N¿Ô°ÓªÌ¡N¤ä«ù¹ÎÅé¡C
b. ±Ð¾É¾A¦XӮץͬ¡«¬ºAªº´î»´À£¤O¤§§Þ¥©¡C
c. ¹ï©ó¦]ºC©ÊÅöíw³y¦¨ªº¸£³¡·l¶Ë¡N¤H®æ»Ùꪺ¦æ¬°°ÝÃD¤©¥H§´µ½³B
²z¤Î¿Ô°Ó¡C
d. ¦^µªÓ®×¦³ÃöEEGÀˬd¤Î¥~¬ì¤â³NªvÀøªº¦UºØ°ÝÃD¡C
e. °sºë¶¼®Æ»Ý¨î¡M¥H¨¾©âÝzµo§@¡C
3. ºû«ù¥¿±`ªÀ¥æ:
a. À°§UӮפF¸ÑªÀ¥æªº»Ýn¡C
b. ´£¨Ñ¤ä«ù¨Ã±j½Õ¨ä¦Ò¶q¿ò¤Î¼~¼{¬O¥¿±`ªº¡C
c. ¨ó§U§ä¨ì¥OӮ׳߷R¥B¤£·|¹L©ó¿E¯Pªº¬¡°Ê¡C
d. ¥[±j¿í±qªvÀøp¹ºªº«n©Ê¡C
e. »P®a¤H¡NªB¤Í©Î¨ä±µÄ²ªº¤Hû°Q½×¯f±¡¡C
f. ¤Þ¾ÉӮצb¦P¾«¹ÎÅ餤»P¤H¤À¨É¸gÅç¡C
¤Q. ¯f¤H±Ð¨|¤Î°·±dºûÅ@
1. ¹ªÀyÓ®×§ä¥X·|³y¦¨©âÝzªº¾É¦]¡M¨Ò¦p: ¤TÀ\¤£©w¡N¯Ê¥FºÎ¯v¡N±¡ºüÀ£
¤O¡C
2. ´£¿ôӮ׿í±qÃĪ«ªvÀø¤è¦¡ªº«n©Ê¡C
3. §i¶DÓ®×Á×§K°sºë¡M¦]¬°·|¤zÂZ§ÜÅöíwÃĪ«ªº¥NÁ¡C
4. ¹ªÀyӮפήaÄݰQ½×¹ïÅöíwªº·Pı¤ÎºA«×¡C
5. ¹ªÀyӮ׬ïÀ¹ÂåÀø¶EÂ_ĵ¥Ü¥d©Î¤â°é¡C
6. ¹ªÀy¾A¤¤ªº¥Í¬¡«¬ºA¥]¬A¹B°Ê¡N¤ßÆF¬¡°Ê¡NÀç¾iªº¶¼¹¡C
7. Á×§K¾r¾p¨T¨®¡C
8. ·Ç³Æ¤â³N®É¡M¥[±j¹ï¤â³Nµ²ªG¤Î¤è¦¡ªº»¡©ú¡C
9. Âश¥i´£¨Ñ¸ê·½¤Î¤ß²z¤ä«ùªº¦P¾«¹ÎÅé¡C
¤Q¤@. µûÈ
A. Ӯׯà¨ÌÂåÅñªAÃÄ¡M¦å¤¤ÃĪ«¿@«×¦b¥¿±`½d³ò¡C
B. ¨S¦³¨ü¶Ë¡C
C. Ó®×¥i°Ï¤À¾A·íªº¬¡°Ê¡C
D. ¥i¨Ï¥Î¤ä«ùªA°È¤ÎÀ£¤O½Õ¾A§Þ¥©¡C
°Ñ¦Ò¸ê®Æ
J¤ë®Sµ¥µÛ¡C(1997)¡C²Ä¤Q¥|³¹: ¯«¸g¨t²Î¯e¯f¤§Å@²z¡C¦¨¤H¤º¥~¬ìÅ@²z(pp:
1117-1127)¡C¶×µØ¡C
Barry, K., & Teixeira, S. (1983). The role of the nurse in the diagnostic
classification and management of epileptic seizures. Journal of
Neurosurgical Nursing, 15(4), 243-249.
Hickey, J. (1992). The clinical practice of neurological and neurosurgical
nursing (3rd ed.). Philadelphia: J.B.Lippincott.
Whiteman, S., Hermann, B.P., & Gordon, A.(1984). Psychopathology in
temporal lobe epilepsy: How great is the risk? Biol Psychiatry, 19, 213-236.
Feinberg, T.E. & Farah, M.J. (1997). Chap. 51: Neurobehavioral aspects
of epilepsy. Behavioral neurology and neuropsychology(pp: 644-649.)
--
* °ê¥ß¤¤¤s¤j¾Ç Formosa BBS * From: 140.117.10.37
|